The Cutting-Edge Technology of AI Prostate Cancer Diagnosis in the Era of Digital Pathology
Digitization brought dramatic changes to the different parts of the healthcare industry. Pathology, a field in which the adoption of digitization has been quite slow compared to other fields, is now poised for the long-awaited transition to digitization. Gaining momentum as a proven and essential technology, digital pathology can be a great solution to resolve problems pathologists are facing increasing workload but not enough human resources to deal with it.
This presentation introduces an AI-powered cancer diagnostic support software for prostate cancer, the most common cancer among males. Integrated to the current workflow, the diagnostic support software can provide pathologists with meaningful benefits including minimizing the risk of human errors from the subjectivity of pathologist assessments, leading to more precise and consistent diagnostic results, and improved reproducibility.
At the same time, the talk elaborates on the cutting-edge deep learning system applied to the diagnostic software space, which overcame its limits for better performance and higher utilization.
At the end of the speech, the values of the cutting-edge technology that encompasses the entire journey of cancer care will be presented: diagnosis, prognosis, treatment.
The speech will enable the audience to gain a better understanding of the AI capabilities that can be integrated into the existing pathology workflow and change the current cancer treatment environment.
For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.
Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.